Jeff Aronin is the CEO and Chairman of Paragon Biosciences. The company identifies a heretofore neglected medical disease, and then creates a new company that will focus on it as its primary goal. Frequently, sufferers of the disease may go undiagnosed or untreated, for lack of proper research and development. The intent is to help solve the patients’ needs specific to the disease. Jeff founded the company in 2009 with that commitment.
It is an innovative formula that has worked very successfully for Jeff Aronin and Paragon Biosciences. The company is known globally for its advancements in the healthcare industry. It invests its funds to develop the companies.
Castle Creek Pharmaceuticals is one of the companies developed as a result. There was a serious need for attending to a dermatologic disease, and that is how this company came about. There is a number near the amount of 6000 diseases that are known to exist, and many of them are in that category.
The increased amount of research for these diseases that has taken place so far, and continues to be an ongoing project of the companies, is tremendous. The company can be credited with the addition of 13 FDA approved drugs now on the market. Jeff Aronin and his whole team make a difference. Jeff Aronin is improving the lives of others by providing them with the much needed option for treatment of their illness.
The clinical trials that are performed to test quality and high user standards are closely monitored by Jeff’s companies. They hold the clinical trials in house, on their own premises, rather than outsourcing them. In this way, they can assure that every facet of the research meets their own high quality standards and integrity.
Jeff Aronin is an American entrepreneur born in 1967. He is highly regarded by others in the industry. Jeff Aronin has been recognized many times for his works, including with the honor of receiving the Ernst & Young’s Entrepreneur of the Year Award. Jeff attended Northern Illinois University, where he obtained his B.S. degree. He also graduated from DePaul University with an M.B.A.